Last week the FDA granted 510(k) clearance to a mobile-based cognitive test called DANA (Defense Automated Neurobehavioral Assessment), which helps healthcare providers better assess the medical or psychological state of their patients. DANA was developed by Silver Spring, Maryland-based AnthroTronix, a digital health R&D company, and it was developed partially thanks to funding from the US Navy Bureau of Medicine and Surgery as well as a Rapid Innovation Fund award from the US Army. The latter led to DANA being used to help evaluate the medical status of deployed military service members in Afghanistan.
“We are pleased that DANA has sought and received FDA clearance, leading the way for this type of game-changing technology,” Corinna Lathan, founder and CEO of AnthroTronix, said in a statement. “In essence, measuring reaction time is like taking the temperature of the brain—like a “Brain Thermometer”—and it is a vital part of the data that a health professional needs to evaluate their patient.” Keep reading>>